Here are relevant reports on : software-development-market
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Orthopedic, Dental), Class of Device (Class I, II, III), Service (Device Development & Manufacturing, Packaging & Assembly, Quality Management) - Global Forecast to 2030
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Synthetic Data Generation Market by Offering (Solution/Platform and Services), Data Type (Tabular, Text, Image, and Video), Application (AI/ML Training & Development, Test Data Management), Vertical and Region - Global Forecast to 2028
The global synthetic data generation size is projected to reach USD 2.1 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 45.7% during the forecast period. Major vendors in the synthetic data generation market include Microsoft (US), Google (US), IBM (US), AWS (US), NVIDIA (US), OpenAI (US), Informatica (US), Broadcom (US), Sogeti (France), Mphasis (India), Databricks (US), MOSTLY AI (Austria), Tonic (US), MDClone (Israel) TCS (India), Hazy (UK), Synthesia (UK), Synthesized (UK), Facteus (US), Anyverse (Spain), Neurolabs (Scotland), Rendered.ai (US), Gretel (US), OneView (Israel), GenRocket (US), YData (US), CVEDIA (UK), Syntheticus (Switzerland), AnyLogic (US), Bifrost AI (US), Anonos (US).
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Citizen Twin Market by Enterprise, Application (Product Design & Development, Performance Monitoring, Predictive Maintenance, Business Optimization), Industry (Aerospace, Automotive & Transportation, Healthcare, Energy & Utility) - Global Forecast to 2030
Citizen Twin Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Game-based Learning Market by Offering (Gamified Learning, Microlearning, Simulation Learning, LMS, Adaptive Learning, Authoring Tools), Application (K-12, Higher Education, Corporate Training, STEM, Cognitive Development) - Global Forecast to 2030
The game-based learning market is expanding rapidly, with a projected market size anticipated to rise from about USD 6.23 billion in 2025 to USD 17.82 billion by 2030, featuring a CAGR of 23.4%. The major players in the game-based learning market include Duolingo (US), Kahoot! (Norway), Skillsoft (US), Pearson (US), Stride Inc. (US), Game Strategies (Spain), Fundamentor (India), Quizizz (US), Tenneo (US), and EI (US).
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
